Listen "Decrypting FDA's Cybersecurity Policy"
Episode Synopsis
Naomi Schwartz, the Senior Director for Cybersecurity Quality & Safety at Medcrypt, a medical device cybersecurity specialty firm, shares some interesting tidbits about FDA's upcoming Refuse-to-Accept (RTA) policy for Cyber Devices and Related Systems. The policy is effective Oct. 1 and Schwartz breaks down what the RTA will mean for medical device manufacturers and their FDA submissions.
More episodes of the podcast Let’s Talk Medtech
How Stereotaxis Is Making Its Mark in Surgical Robotics: A Journey from Survival to Success
01/12/2025
Audacity Drives Innovation in Medtech
03/11/2025
Medtech Industry Health Check: Tariff Impacts, Hot Segments, and the Rise of Mid-Tier Companies
12/10/2025
Building a Stronger & Better AngioDynamics
02/09/2025
Medical Device Industry Mid-Year Trends 2025
18/08/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.